Skip to main content

Table 2 clinical presentation of the studied groups

From: IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals

  Cirrhosis group
N=50(%)
HCC group
N=50(%)
Test of significance
Hepatic encephalopathy 8 (16.0) 20 (40.0) χ2=7.14
p=0.008*
Ascites 17 (34.0) 27 (54.0) χ2=4.06
p=0.04*
Jaundice 11 (22.0) 26 (52.0) χ2=9.65
p=0.001*
Hematemesis 26 (52.0) 37 (74.0) χ2=5.19
p=0.023*
DM 20 (40.0) 18 (36.0) χ2=0.170
p=0.680
  1. *Statistically significant (if p< 0.05)